Differential Expression Analysis
EB / P Comparison
Note: The Fold Change value for up-regulated genes is displayed in red; down-regulated values are displayed in blue.
| Gene | Annotation | pval | Fold Change (log2ratio) |
|---|---|---|---|
| hbb-bh1 | hemoglobin Z, beta-like embryonic chain | 7.065e-6 | 6.598e+0 |
| loc100044263 | hypothetical protein LOC100044263 | 1.651e-5 | 6.222e+0 |
| hapln1 | hyaluronan and proteoglycan link protein 1 | 1.598e-8 | 5.011e+0 |
| tspan12 | tetraspanin 12 | 4.318e-11 | 4.782e+0 |
| gsta4 | glutathione S-transferase, alpha 4 | 5.150e-10 | 4.708e+0 |
| unc5c | unc-5 homolog C (C. elegans) | 8.414e-8 | 4.692e+0 |
| hba-x | hemoglobin X, alpha-like embryonic chain in Hba complex | 1.665e-3 | 4.615e+0 |
| cap2 | CAP, adenylate cyclase-associated protein, 2 (yeast) | 3.659e-10 | 4.394e+0 |
| tmco2 | transmembrane and coiled-coil domains 2 | 1.661e-9 | 4.346e+0 |
| etv2 | ets variant gene 2 | 9.678e-11 | 4.313e+0 |
| eda2r | ectodysplasin A2 isoform receptor | 5.458e-9 | 4.310e+0 |
| eraf | erythroid associated factor | 3.441e-5 | 4.309e+0 |
| gstm2 | glutathione S-transferase, mu 2 | 6.601e-7 | 4.303e+0 |
| bc061212 | cDNA sequence BC061212 | 1.200e-5 | 4.033e+0 |
| cth | cystathionase (cystathionine gamma-lyase) | 2.229e-6 | 3.994e+0 |
| hoxd1 | homeo box D1 | 1.854e-10 | 3.990e+0 |
| a930009l07rik | RIKEN cDNA A930009L07 gene | 5.687e-8 | 3.942e+0 |
| loc100046086 | similar to dHand protein | 1.115e-6 | 3.935e+0 |
| bmp4 | bone morphogenetic protein 4 | 7.355e-7 | 3.859e+0 |
| heph | hephaestin | 5.047e-7 | 3.850e+0 |
| gad2 | glutamic acid decarboxylase 2 | 3.304e-6 | 3.835e+0 |
| gypa | glycophorin A | 7.104e-6 | 3.823e+0 |
| rnd2 | Rho family GTPase 2 | 1.099e-7 | 3.702e+0 |
| igf1 | insulin-like growth factor 1 | 3.928e-6 | 3.632e+0 |
| gchfr | GTP cyclohydrolase I feedback regulator | 7.896e-7 | 3.594e+0 |
| fat1 | FAT tumor suppressor homolog 1 (Drosophila) | 1.263e-3 | 3.580e+0 |
| bc023969 | cDNA sequence BC023969 | 5.761e-8 | 3.559e+0 |
| mest | mesoderm specific transcript | 9.983e-4 | 3.463e+0 |
| gm784 | gene model 784, (NCBI) | 1.823e-5 | 3.433e+0 |
| scd1 | stearoyl-Coenzyme A desaturase 1 | 1.751e-3 | 3.344e+0 |
| sox18 | SRY-box containing gene 18 | 6.687e-5 | 3.330e+0 |
| aplnr | apelin receptor | 7.488e-4 | 3.304e+0 |
| phlda3 | pleckstrin homology-like domain, family A, member 3 | 3.316e-7 | 3.285e+0 |
| reln | reelin | 2.763e-8 | 3.242e+0 |
| 2310016c16rik | RIKEN cDNA 2310016C16 gene | 1.758e-5 | 3.238e+0 |
| hmgcs1 | 3-hydroxy-3-methylglutaryl-Coenzyme A synthase 1 | 2.462e-9 | 3.138e+0 |
| 9230110c19rik | RIKEN cDNA 9230110C19 gene | 2.711e-8 | 3.114e+0 |
| hoxd8 | homeo box D8 | 2.041e-5 | 3.110e+0 |
| aard | alanine and arginine rich domain containing protein | 8.146e-4 | 3.092e+0 |
| prtg | protogenin homolog (Gallus gallus) | 5.625e-10 | 3.071e+0 |
| 9230114k14rik | RIKEN cDNA 9230114K14 gene | 1.181e-6 | 3.071e+0 |
| slc38a4 | solute carrier family 38, member 4 | 4.649e-3 | 3.052e+0 |
| snca | synuclein, alpha | 5.196e-6 | 3.028e+0 |
| snurf | SNRPN upstream reading frame | 1.102e-5 | 3.015e+0 |
| sc4mol | sterol-C4-methyl oxidase-like | 3.090e-7 | 3.011e+0 |
| ccnb1ip1 | cyclin B1 interacting protein 1 | 8.267e-6 | 2.990e+0 |
| has2 | hyaluronan synthase 2 | 9.136e-6 | 2.967e+0 |
| tmem163 | transmembrane protein 163 | 5.131e-7 | 2.966e+0 |
| ephb4 | Eph receptor B4 | 1.839e-5 | 2.950e+0 |
| fhit | fragile histidine triad gene | 1.380e-5 | 2.909e+0 |
| mageh1 | melanoma antigen, family H, 1 | 5.813e-4 | 2.886e+0 |
| mvd | mevalonate (diphospho) decarboxylase | 1.627e-8 | 2.870e+0 |
| peg10 | paternally expressed 10 | 4.483e-3 | 2.847e+0 |
| slc7a3 | solute carrier family 7 (cationic amino acid transporter, y+ system), member 3 | 4.443e-4 | 2.845e+0 |
| b9d1 | B9 protein domain 1 | 2.450e-6 | 2.809e+0 |
| snhg3 | small nucleolar RNA host gene (non-protein coding) 3 | 9.925e-6 | 2.791e+0 |
| sall4 | sal-like 4 (Drosophila) | 7.000e-4 | 2.791e+0 |
| rspo3 | R-spondin 3 homolog (Xenopus laevis) | 6.953e-7 | 2.777e+0 |
| 2610019f03rik | RIKEN cDNA 2610019F03 gene | 1.333e-6 | 2.732e+0 |
| wnk4 | WNK lysine deficient protein kinase 4 | 1.684e-6 | 2.720e+0 |
| tead1 | TEA domain family member 1 | 2.581e-3 | 2.700e+0 |
| ddah1 | dimethylarginine dimethylaminohydrolase 1 | 3.460e-6 | 2.695e+0 |
| lrp11 | low density lipoprotein receptor-related protein 11 | 5.050e-7 | 2.673e+0 |
| wasf1 | WASP family 1 | 2.129e-6 | 2.671e+0 |
| gfi1b | growth factor independent 1B | 2.861e-10 | 2.671e+0 |
| lyplal1 | lysophospholipase-like 1 | 3.152e-6 | 2.671e+0 |
| gucy1a3 | guanylate cyclase 1, soluble, alpha 3 | 8.002e-7 | 2.636e+0 |
| klf1 | Kruppel-like factor 1 (erythroid) | 2.956e-5 | 2.610e+0 |
| pdzk1ip1 | PDZK1 interacting protein 1 | 2.403e-8 | 2.610e+0 |
| tmem47 | transmembrane protein 47 | 9.128e-7 | 2.604e+0 |
| adat2 | adenosine deaminase, tRNA-specific 2, TAD2 homolog (S. cerevisiae) | 1.649e-6 | 2.598e+0 |
| ccdc25 | coiled-coil domain containing 25 | 2.040e-5 | 2.586e+0 |
| rhoj | ras homolog gene family, member J | 1.229e-4 | 2.577e+0 |
| eg434402 | predicted gene, EG434402 | 5.596e-5 | 2.566e+0 |
| blvrb | biliverdin reductase B (flavin reductase (NADPH)) | 2.461e-5 | 2.564e+0 |
| 5930412g12rik | RIKEN cDNA 5930412G12 gene | 2.317e-8 | 2.564e+0 |
| 2210419i08rik | RIKEN cDNA 2210419I08 gene | 3.418e-7 | 2.562e+0 |
| bc004728 | cDNA sequence BC004728 | 1.122e-6 | 2.561e+0 |
| d10627 | cDNA sequence D10627 | 1.316e-5 | 2.529e+0 |
| pard3 | par-3 (partitioning defective 3) homolog (C. elegans) | 4.554e-5 | 2.516e+0 |
| fgf10 | fibroblast growth factor 10 | 9.112e-6 | 2.512e+0 |
| 2610019e17rik | RIKEN cDNA 2610019E17 gene | 4.256e-4 | 2.501e+0 |
| ppcs | phosphopantothenoylcysteine synthetase | 3.732e-6 | 2.474e+0 |
| gfra2 | glial cell line derived neurotrophic factor family receptor alpha 2 | 1.333e-5 | 2.469e+0 |
| ottmusg00000011070 | predicted gene, OTTMUSG00000011070 | 5.040e-7 | 2.464e+0 |
| hoxb5 | homeo box B5 | 1.327e-4 | 2.460e+0 |
| trp53inp1 | transformation related protein 53 inducible nuclear protein 1 | 1.085e-7 | 2.455e+0 |
| slc30a10 | solute carrier family 30, member 10 | 1.552e-7 | 2.447e+0 |
| fgf13 | fibroblast growth factor 13 | 3.027e-7 | 2.440e+0 |
| tal1 | T-cell acute lymphocytic leukemia 1 | 1.025e-7 | 2.437e+0 |
| lhfp | lipoma HMGIC fusion partner | 3.081e-3 | 2.413e+0 |
| asna1 | arsA arsenite transporter, ATP-binding, homolog 1 (bacterial) | 8.105e-5 | 2.410e+0 |
| nckap1 | NCK-associated protein 1 | 4.174e-3 | 2.408e+0 |
| slc39a8 | solute carrier family 39 (metal ion transporter), member 8 | 4.843e-7 | 2.389e+0 |
| 1700019n12rik | RIKEN cDNA 1700019N12 gene | 1.747e-5 | 2.389e+0 |
| them2 | thioesterase superfamily member 2 | 6.837e-7 | 2.387e+0 |
| 2410022l05rik | RIKEN cDNA 2410022L05 gene | 2.563e-9 | 2.385e+0 |
| rbm24 | RNA binding motif protein 24 | 2.881e-7 | 2.384e+0 |
| efs | embryonal Fyn-associated substrate | 7.493e-4 | 2.384e+0 |
| rprm | reprimo, TP53 dependent G2 arrest mediator candidate | 5.477e-7 | 2.372e+0 |
| hoxb2 | homeo box B2 | 6.505e-7 | 2.363e+0 |
| clec1b | C-type lectin domain family 1, member b | 2.370e-3 | 2.352e+0 |
| tead2 | TEA domain family member 2 | 2.438e-4 | 2.329e+0 |
| hebp1 | heme binding protein 1 | 4.241e-5 | 2.327e+0 |
| fbn2 | fibrillin 2 | 2.801e-4 | 2.316e+0 |
| gng11 | guanine nucleotide binding protein (G protein), gamma 11 | 4.769e-7 | 2.294e+0 |
| dbc1 | deleted in bladder cancer 1 (human) | 5.628e-6 | 2.289e+0 |
| ai429214 | expressed sequence AI429214 | 3.042e-6 | 2.284e+0 |
| 8030447m02rik | RIKEN cDNA 8030447M02 gene | 3.014e-3 | 2.279e+0 |
| tspan18 | tetraspanin 18 | 2.096e-7 | 2.276e+0 |
| zmat3 | zinc finger matrin type 3 | 9.826e-7 | 2.273e+0 |
| kdr | kinase insert domain protein receptor | 1.551e-3 | 2.270e+0 |
| mdk | midkine | 2.964e-5 | 2.254e+0 |
| nup35 | nucleoporin 35 | 9.984e-5 | 2.244e+0 |
| ccng1 | cyclin G1 | 1.115e-5 | 2.221e+0 |
| gulp1 | GULP, engulfment adaptor PTB domain containing 1 | 8.422e-7 | 2.220e+0 |
| 1700025k23rik | RIKEN cDNA 1700025K23 gene | 2.853e-4 | 2.213e+0 |
| 4833414e09rik | RIKEN cDNA 4833414E09 gene | 2.595e-4 | 2.198e+0 |
| 2610024b07rik | RIKEN cDNA 2610024B07 gene | 2.903e-3 | 2.194e+0 |
| efcab7 | EF-hand calcium binding domain 7 | 2.226e-4 | 2.190e+0 |
| ppp1r14c | protein phosphatase 1, regulatory (inhibitor) subunit 14c | 2.465e-5 | 2.186e+0 |
| lin28 | lin-28 homolog (C. elegans) | 8.754e-6 | 2.173e+0 |
| 1500011k16rik | RIKEN cDNA 1500011K16 gene | 1.068e-4 | 2.165e+0 |
| ngrn | neugrin, neurite outgrowth associated | 3.308e-5 | 2.156e+0 |
| rab34 | RAB34, member of RAS oncogene family | 4.426e-7 | 2.156e+0 |
| pik3r3 | phosphatidylinositol 3 kinase, regulatory subunit, polypeptide 3 (p55) | 2.414e-4 | 2.155e+0 |
| itm2a | integral membrane protein 2A | 2.287e-5 | 2.151e+0 |
| me1 | malic enzyme 1, NADP(+)-dependent, cytosolic | 8.359e-4 | 2.143e+0 |
| serpinh1 | serine (or cysteine) peptidase inhibitor, clade H, member 1 | 3.223e-2 | 2.138e+0 |
| lss | lanosterol synthase | 2.175e-7 | 2.131e+0 |
| chchd5 | coiled-coil-helix-coiled-coil-helix domain containing 5 | 6.826e-7 | 2.127e+0 |
| nat2 | N-acetyltransferase 2 (arylamine N-acetyltransferase) | 7.325e-5 | 2.124e+0 |
| loc66376 | hypothetical LOC66376 | 5.657e-5 | 2.120e+0 |
| nit2 | nitrilase family, member 2 | 1.989e-5 | 2.120e+0 |
| asb4 | ankyrin repeat and SOCS box-containing 4 | 3.272e-3 | 2.109e+0 |
| mgmt | O-6-methylguanine-DNA methyltransferase | 1.002e-6 | 2.105e+0 |
| zfpm2 | zinc finger protein, multitype 2 | 2.053e-7 | 2.101e+0 |
| 6230427j02rik | RIKEN cDNA 6230427J02 gene | 1.192e-8 | 2.096e+0 |
| bc003267 | cDNA sequence BC003267 | 1.905e-4 | 2.095e+0 |
| shroom2 | shroom family member 2 | 4.213e-4 | 2.093e+0 |
| gria2 | glutamate receptor, ionotropic, AMPA2 (alpha 2) | 1.207e-7 | 2.093e+0 |
| rasl11a | RAS-like, family 11, member A | 1.560e-4 | 2.092e+0 |
| 2700081l22rik | RIKEN cDNA 2700081L22 gene | 4.747e-3 | 2.083e+0 |
| fbxo25 | F-box protein 25 | 1.947e-5 | 2.065e+0 |
| ctse | cathepsin E | 8.345e-5 | 2.064e+0 |
| gcom1 | GRINL1A complex locus | 7.549e-4 | 2.060e+0 |
| hoxd9 | homeo box D9 | 3.549e-4 | 2.044e+0 |
| igfbp5 | insulin-like growth factor binding protein 5 | 1.537e-3 | 2.042e+0 |
| cdh5 | cadherin 5 | 4.288e-3 | 2.041e+0 |
| psrc1 | proline/serine-rich coiled-coil 1 | 6.847e-9 | 2.029e+0 |
| hist1h2ae | histone cluster 1, H2ae | 1.477e-2 | 2.024e+0 |
| irs2 | insulin receptor substrate 2 | 4.862e-5 | 2.023e+0 |
| zfp97 | zinc finger protein 97 | 2.485e-7 | 2.022e+0 |
| igf2 | insulin-like growth factor 2 | 4.005e-3 | 2.021e+0 |
| pin1 | protein (peptidyl-prolyl cis/trans isomerase) NIMA-interacting 1 | 4.710e-4 | 2.019e+0 |
| c77648 | expressed sequence C77648 | 1.570e-3 | 2.017e+0 |
| hexim2 | hexamthylene bis-acetamide inducible 2 | 1.593e-6 | 2.014e+0 |
| smtnl2 | smoothelin-like 2 | 3.338e-7 | 2.013e+0 |
| 3110040n11rik | RIKEN cDNA 3110040N11 gene | 6.430e-6 | 2.009e+0 |
| mrpl53 | mitochondrial ribosomal protein L53 | 2.695e-5 | 2.002e+0 |
| diap2 | diaphanous homolog 2 (Drosophila) | 1.073e-5 | -2.001e+0 |
| skil | SKI-like | 7.899e-7 | -2.002e+0 |
| expi | extracellular proteinase inhibitor | 5.302e-4 | -2.007e+0 |
| cxcl16 | chemokine (C-X-C motif) ligand 16 | 2.416e-2 | -2.009e+0 |
| 5730508b09rik | RIKEN cDNA 5730508B09 gene | 1.220e-3 | -2.011e+0 |
| rabgap1l | RAB GTPase activating protein 1-like | 2.712e-7 | -2.020e+0 |
| fcrls | Fc receptor-like S, scavenger receptor | 3.096e-2 | -2.021e+0 |
| runx2 | runt related transcription factor 2 | 5.064e-5 | -2.022e+0 |
| pdcd1lg2 | programmed cell death 1 ligand 2 | 9.096e-4 | -2.024e+0 |
| d12ertd647e | DNA segment, Chr 12, ERATO Doi 647, expressed | 4.031e-7 | -2.025e+0 |
| il18 | interleukin 18 | 1.090e-2 | -2.025e+0 |
| irf5 | interferon regulatory factor 5 | 1.908e-4 | -2.029e+0 |
| c5ar1 | complement component 5a receptor 1 | 3.197e-2 | -2.029e+0 |
| traf3 | Tnf receptor-associated factor 3 | 6.888e-7 | -2.031e+0 |
| fabp4 | fatty acid binding protein 4, adipocyte | 5.946e-3 | -2.035e+0 |
| lilrb3 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 3 | 6.098e-4 | -2.041e+0 |
| myo5a | myosin Va | 6.229e-5 | -2.045e+0 |
| malt1 | mucosa associated lymphoid tissue lymphoma translocation gene 1 | 8.630e-4 | -2.047e+0 |
| loc625360 | similar to 2-cell-stage, variable group, member 3 | 1.079e-2 | -2.049e+0 |
| naip5 | NLR family, apoptosis inhibitory protein 5 | 4.733e-4 | -2.051e+0 |
| lrmp | lymphoid-restricted membrane protein | 2.183e-5 | -2.051e+0 |
| tnfrsf12a | tumor necrosis factor receptor superfamily, member 12a | 5.138e-5 | -2.052e+0 |
| 9430027b09rik | RIKEN cDNA 9430027B09 gene | 2.326e-5 | -2.052e+0 |
| bex6 | brain expressed gene 6 | 2.472e-3 | -2.052e+0 |
| qpct | glutaminyl-peptide cyclotransferase (glutaminyl cyclase) | 1.069e-2 | -2.052e+0 |
| myo1f | myosin IF | 1.735e-5 | -2.053e+0 |
| cd84 | CD84 antigen | 4.276e-4 | -2.056e+0 |
| arhgef6 | Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6 | 3.837e-6 | -2.060e+0 |
| pik3r5 | phosphoinositide-3-kinase, regulatory subunit 5, p101 | 1.251e-3 | -2.062e+0 |
| tcrb-v8.2 | T-cell receptor beta, variable 8.2 | 4.680e-4 | -2.063e+0 |
| rac2 | RAS-related C3 botulinum substrate 2 | 4.403e-6 | -2.069e+0 |
| pglyrp2 | peptidoglycan recognition protein 2 | 1.619e-4 | -2.070e+0 |
| ifitm6 | interferon induced transmembrane protein 6 | 1.810e-2 | -2.072e+0 |
| 1110017f19rik | RIKEN cDNA 1110017F19 gene | 1.213e-4 | -2.072e+0 |
| zfp52 | zinc finger protein 52 | 3.300e-6 | -2.073e+0 |
| plekha2 | pleckstrin homology domain-containing, family A (phosphoinositide binding specific) member 2 | 2.916e-5 | -2.077e+0 |
| psmb8 | proteasome (prosome, macropain) subunit, beta type 8 (large multifunctional peptidase 7) | 6.891e-6 | -2.079e+0 |
| stk10 | serine/threonine kinase 10 | 8.954e-6 | -2.080e+0 |
| 4930523c07rik | RIKEN cDNA 4930523C07 gene | 5.391e-7 | -2.080e+0 |
| vwf | Von Willebrand factor homolog | 4.289e-3 | -2.081e+0 |
| 1700097n02rik | RIKEN cDNA 1700097N02 gene | 3.299e-5 | -2.084e+0 |
| tmem98 | transmembrane protein 98 | 3.675e-5 | -2.084e+0 |
| ptger3 | prostaglandin E receptor 3 (subtype EP3) | 4.226e-5 | -2.085e+0 |
| epsti1 | epithelial stromal interaction 1 (breast) | 7.576e-5 | -2.089e+0 |
| thbs1 | thrombospondin 1 | 4.729e-2 | -2.094e+0 |
| elmo1 | engulfment and cell motility 1, ced-12 homolog (C. elegans) | 2.204e-5 | -2.095e+0 |
| gpnmb | glycoprotein (transmembrane) nmb | 2.592e-2 | -2.097e+0 |
| metrnl | meteorin, glial cell differentiation regulator-like | 7.573e-4 | -2.099e+0 |
| slpi | secretory leukocyte peptidase inhibitor | 2.336e-2 | -2.100e+0 |
| 2310058n22rik | RIKEN cDNA 2310058N22 gene | 6.990e-4 | -2.101e+0 |
| eps8 | epidermal growth factor receptor pathway substrate 8 | 3.689e-3 | -2.102e+0 |
| cd86 | CD86 antigen | 3.370e-3 | -2.102e+0 |
| galnt12 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 12 | 1.638e-4 | -2.103e+0 |
| 9030619p08rik | RIKEN cDNA 9030619P08 gene | 5.566e-4 | -2.103e+0 |
| mettl7a1 | methyltransferase like 7A1 | 4.356e-6 | -2.107e+0 |
| gsdmd | gasdermin D | 6.386e-6 | -2.108e+0 |
| atp2b4 | ATPase, Ca++ transporting, plasma membrane 4 | 6.890e-3 | -2.112e+0 |
| csf3r | colony stimulating factor 3 receptor (granulocyte) | 3.422e-5 | -2.118e+0 |
| acot1 | acyl-CoA thioesterase 1 | 1.071e-4 | -2.125e+0 |
| oasl1 | 2'-5' oligoadenylate synthetase-like 1 | 3.262e-2 | -2.127e+0 |
| aqp9 | aquaporin 9 | 3.665e-4 | -2.127e+0 |
| ugt1a9 | UDP glucuronosyltransferase 1 family, polypeptide A9 | 7.657e-4 | -2.128e+0 |
| 4930506m07rik | RIKEN cDNA 4930506M07 gene | 2.192e-2 | -2.129e+0 |
| loc552908 | hypothetical LOC552908 | 8.368e-4 | -2.130e+0 |
| ptgir | prostaglandin I receptor (IP) | 2.277e-5 | -2.132e+0 |
| lgals3bp | lectin, galactoside-binding, soluble, 3 binding protein | 4.980e-3 | -2.132e+0 |
| pmepa1 | prostate transmembrane protein, androgen induced 1 | 1.091e-5 | -2.133e+0 |
| rnase6 | ribonuclease, RNase A family, 6 | 2.583e-4 | -2.134e+0 |
| tmem40 | transmembrane protein 40 | 1.368e-6 | -2.141e+0 |
| hist3h2a | histone cluster 3, H2a | 6.408e-6 | -2.150e+0 |
| etv5 | ets variant gene 5 | 1.449e-6 | -2.151e+0 |
| 2610528a11rik | RIKEN cDNA 2610528A11 gene | 3.515e-5 | -2.164e+0 |
| mxd1 | MAX dimerization protein 1 | 7.184e-7 | -2.164e+0 |
| 4831426i19rik | RIKEN cDNA 4831426I19 gene | 2.143e-4 | -2.171e+0 |
| slc45a3 | solute carrier family 45, member 3 | 1.789e-6 | -2.171e+0 |
| tlr1 | toll-like receptor 1 | 2.426e-2 | -2.175e+0 |
| rnasel | ribonuclease L (2', 5'-oligoisoadenylate synthetase-dependent) | 8.443e-7 | -2.175e+0 |
| endod1 | endonuclease domain containing 1 | 7.688e-9 | -2.177e+0 |
| c730049o14rik | RIKEN cDNA C730049O14 gene | 2.559e-6 | -2.178e+0 |
| ccr5 | chemokine (C-C motif) receptor 5 | 1.573e-2 | -2.187e+0 |
| arhgap30 | Rho GTPase activating protein 30 | 2.845e-5 | -2.187e+0 |
| vill | villin-like | 1.366e-5 | -2.188e+0 |
| slamf7 | SLAM family member 7 | 2.464e-2 | -2.189e+0 |
| csf2rb2 | colony stimulating factor 2 receptor, beta 2, low-affinity (granulocyte-macrophage) | 8.347e-4 | -2.190e+0 |
| arhgef3 | Rho guanine nucleotide exchange factor (GEF) 3 | 1.330e-5 | -2.192e+0 |
| apoc2 | apolipoprotein C-II | 2.265e-2 | -2.194e+0 |
| oas1g | 2'-5' oligoadenylate synthetase 1G | 7.480e-3 | -2.197e+0 |
| ethe1 | ethylmalonic encephalopathy 1 | 9.558e-6 | -2.197e+0 |
| a630001g21rik | RIKEN cDNA A630001G21 gene | 4.365e-5 | -2.198e+0 |
| p2rx7 | purinergic receptor P2X, ligand-gated ion channel, 7 | 5.701e-6 | -2.199e+0 |
| nlrx1 | NLR family member X1 | 2.401e-6 | -2.201e+0 |
| sema4a | sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A | 3.381e-3 | -2.202e+0 |
| d12ertd553e | DNA segment, Chr 12, ERATO Doi 553, expressed | 6.134e-5 | -2.203e+0 |
| foxp1 | forkhead box P1 | 5.972e-7 | -2.204e+0 |
| hcls1 | hematopoietic cell specific Lyn substrate 1 | 7.548e-5 | -2.208e+0 |
| tmem173 | transmembrane protein 173 | 4.738e-5 | -2.210e+0 |
| nap1l5 | nucleosome assembly protein 1-like 5 | 2.066e-4 | -2.214e+0 |
| slc16a7 | solute carrier family 16 (monocarboxylic acid transporters), member 7 | 8.263e-4 | -2.215e+0 |
| trpc6 | transient receptor potential cation channel, subfamily C, member 6 | 2.345e-4 | -2.217e+0 |
| abcg3 | ATP-binding cassette, sub-family G (WHITE), member 3 | 1.361e-3 | -2.220e+0 |
| oas3 | 2'-5' oligoadenylate synthetase 3 | 4.221e-2 | -2.223e+0 |
| arsb | arylsulfatase B | 6.780e-6 | -2.225e+0 |
| gpr137b-ps | G protein-coupled receptor 137B, pseudogene | 1.007e-4 | -2.235e+0 |
| hps5 | Hermansky-Pudlak syndrome 5 homolog (human) | 9.828e-5 | -2.236e+0 |
| 4732429d16rik | RIKEN cDNA 4732429D16 gene | 7.454e-3 | -2.236e+0 |
| sgk3 | serum/glucocorticoid regulated kinase 3 | 1.780e-4 | -2.240e+0 |
| isg20 | interferon-stimulated protein | 1.079e-3 | -2.240e+0 |
| 3830417a13rik | RIKEN cDNA 3830417A13 gene | 3.357e-2 | -2.241e+0 |
| h2-dmb2 | histocompatibility 2, class II, locus Mb2 | 1.985e-3 | -2.247e+0 |
| casp1 | caspase 1 | 1.534e-2 | -2.250e+0 |
| dusp8 | dual specificity phosphatase 8 | 3.498e-7 | -2.254e+0 |
| irak3 | interleukin-1 receptor-associated kinase 3 | 7.646e-5 | -2.255e+0 |
| coro1a | coronin, actin binding protein 1A | 2.209e-6 | -2.256e+0 |
| tsix | X (inactive)-specific transcript, antisense | 5.256e-7 | -2.258e+0 |
| gpr84 | G protein-coupled receptor 84 | 3.951e-4 | -2.260e+0 |
| a130071d04rik | RIKEN cDNA A130071D04 gene | 2.890e-4 | -2.260e+0 |
| parp12 | poly (ADP-ribose) polymerase family, member 12 | 5.291e-3 | -2.264e+0 |
| h2-q8 | histocompatibility 2, Q region locus 8 | 1.110e-2 | -2.264e+0 |
| gda | guanine deaminase | 1.330e-2 | -2.267e+0 |
| arhgap9 | Rho GTPase activating protein 9 | 4.083e-5 | -2.268e+0 |
| igsf6 | immunoglobulin superfamily, member 6 | 4.367e-3 | -2.268e+0 |
| parp3 | poly (ADP-ribose) polymerase family, member 3 | 1.005e-7 | -2.270e+0 |
| prtn3 | proteinase 3 | 1.637e-5 | -2.270e+0 |
| gfi1 | growth factor independent 1 | 4.374e-4 | -2.272e+0 |
| gch1 | GTP cyclohydrolase 1 | 1.864e-4 | -2.277e+0 |
| runx3 | runt related transcription factor 3 | 5.359e-8 | -2.281e+0 |
| 2010001m09rik | RIKEN cDNA 2010001M09 gene | 5.741e-5 | -2.288e+0 |
| gna14 | guanine nucleotide binding protein, alpha 14 | 5.704e-7 | -2.295e+0 |
| ai451617 | expressed sequence AI451617 | 1.953e-3 | -2.295e+0 |
| abcc4 | ATP-binding cassette, sub-family C (CFTR/MRP), member 4 | 4.811e-6 | -2.296e+0 |
| tlr13 | toll-like receptor 13 | 1.061e-2 | -2.298e+0 |
| rnpep | arginyl aminopeptidase (aminopeptidase B) | 2.365e-5 | -2.300e+0 |
| ms4a2 | membrane-spanning 4-domains, subfamily A, member 2 | 1.773e-3 | -2.302e+0 |
| fndc3b | fibronectin type III domain containing 3B | 2.268e-3 | -2.306e+0 |
| slfn8 | schlafen 8 | 3.337e-3 | -2.307e+0 |
| glis3 | GLIS family zinc finger 3 | 4.209e-4 | -2.311e+0 |
| bc023892 | cDNA sequence BC023892 | 2.676e-4 | -2.312e+0 |
| 1810033b17rik | RIKEN cDNA 1810033B17 gene | 9.444e-3 | -2.314e+0 |
| ccdc88b | coiled-coil domain containing 88B | 1.100e-6 | -2.316e+0 |
| pstpip1 | proline-serine-threonine phosphatase-interacting protein 1 | 2.388e-8 | -2.319e+0 |
| itgb7 | integrin beta 7 | 1.744e-5 | -2.321e+0 |
| fxyd5 | FXYD domain-containing ion transport regulator 5 | 4.000e-5 | -2.327e+0 |
| pdk4 | pyruvate dehydrogenase kinase, isoenzyme 4 | 6.898e-6 | -2.327e+0 |
| ccnd1 | cyclin D1 | 2.101e-8 | -2.327e+0 |
| cfp | complement factor properdin | 4.316e-4 | -2.333e+0 |
| fosl2 | fos-like antigen 2 | 1.903e-6 | -2.334e+0 |
| egr3 | early growth response 3 | 1.534e-8 | -2.339e+0 |
| gpr174 | G protein-coupled receptor 174 | 7.040e-6 | -2.342e+0 |
| tnfrsf13b | tumor necrosis factor receptor superfamily, member 13b | 2.737e-4 | -2.347e+0 |
| serinc3 | serine incorporator 3 | 3.864e-8 | -2.349e+0 |
| dennd4a | DENN/MADD domain containing 4A | 5.695e-6 | -2.350e+0 |
| ppm1h | protein phosphatase 1H (PP2C domain containing) | 7.061e-5 | -2.352e+0 |
| mlkl | mixed lineage kinase domain-like | 1.964e-4 | -2.358e+0 |
| c3 | complement component 3 | 9.780e-3 | -2.359e+0 |
| itpkb | inositol 1,4,5-trisphosphate 3-kinase B | 6.701e-5 | -2.362e+0 |
| cd37 | CD37 antigen | 3.721e-7 | -2.365e+0 |
| plagl1 | pleiomorphic adenoma gene-like 1 | 3.824e-4 | -2.369e+0 |
| a430107d22rik | RIKEN cDNA A430107D22 gene | 1.815e-5 | -2.369e+0 |
| dab2 | disabled homolog 2 (Drosophila) | 4.330e-3 | -2.371e+0 |
| il2rg | interleukin 2 receptor, gamma chain | 2.693e-6 | -2.377e+0 |
| acp5 | acid phosphatase 5, tartrate resistant | 5.578e-4 | -2.384e+0 |
| spata13 | spermatogenesis associated 13 | 1.740e-7 | -2.387e+0 |
| hpse | heparanase | 3.255e-4 | -2.388e+0 |
| b4galnt1 | beta-1,4-N-acetyl-galactosaminyl transferase 1 | 3.793e-6 | -2.393e+0 |
| chst11 | carbohydrate sulfotransferase 11 | 2.925e-7 | -2.396e+0 |
| plk2 | polo-like kinase 2 (Drosophila) | 1.641e-5 | -2.401e+0 |
| dock2 | dedicator of cyto-kinesis 2 | 6.694e-7 | -2.401e+0 |
| gria3 | glutamate receptor, ionotropic, AMPA3 (alpha 3) | 6.864e-5 | -2.404e+0 |
| c230093n12rik | RIKEN cDNA C230093N12 gene | 1.976e-7 | -2.406e+0 |
| rnf19b | ring finger protein 19B | 8.681e-5 | -2.410e+0 |
| cdh1 | cadherin 1 | 2.291e-2 | -2.411e+0 |
| dsp | desmoplakin | 1.580e-2 | -2.412e+0 |
| camk1d | calcium/calmodulin-dependent protein kinase ID | 1.207e-5 | -2.414e+0 |
| nmi | N-myc (and STAT) interactor | 4.681e-4 | -2.414e+0 |
| spic | Spi-C transcription factor (Spi-1/PU.1 related) | 2.951e-2 | -2.414e+0 |
| met | met proto-oncogene | 1.268e-4 | -2.417e+0 |
| a630077b13rik | RIKEN cDNA A630077B13 gene | 3.136e-3 | -2.424e+0 |
| kcnk6 | potassium inwardly-rectifying channel, subfamily K, member 6 | 3.805e-6 | -2.426e+0 |
| gbp2 | guanylate binding protein 2 | 1.394e-3 | -2.427e+0 |
| lgals9 | lectin, galactose binding, soluble 9 | 7.000e-6 | -2.429e+0 |
| pik3cg | phosphoinositide-3-kinase, catalytic, gamma polypeptide | 5.415e-6 | -2.432e+0 |
| msrb3 | methionine sulfoxide reductase B3 | 2.242e-5 | -2.437e+0 |
| kcnab2 | potassium voltage-gated channel, shaker-related subfamily, beta member 2 | 2.850e-6 | -2.441e+0 |
| emcn | endomucin | 1.574e-3 | -2.453e+0 |
| gatm | glycine amidinotransferase (L-arginine:glycine amidinotransferase) | 4.840e-4 | -2.457e+0 |
| jun | Jun oncogene | 4.547e-7 | -2.467e+0 |
| itgb2 | integrin beta 2 | 2.344e-5 | -2.469e+0 |
| jarid1d | jumonji, AT rich interactive domain 1D (Rbp2 like) | 1.362e-4 | -2.470e+0 |
| 4930431b09rik | RIKEN cDNA 4930431B09 gene | 2.085e-3 | -2.472e+0 |
| cd72 | CD72 antigen | 4.391e-3 | -2.488e+0 |
| mefv | Mediterranean fever | 1.068e-2 | -2.492e+0 |
| nr4a2 | nuclear receptor subfamily 4, group A, member 2 | 4.533e-7 | -2.494e+0 |
| tlr2 | toll-like receptor 2 | 4.568e-3 | -2.494e+0 |
| c3ar1 | complement component 3a receptor 1 | 3.543e-2 | -2.495e+0 |
| birc3 | baculoviral IAP repeat-containing 3 | 3.704e-9 | -2.499e+0 |
| dlk1 | delta-like 1 homolog (Drosophila) | 1.112e-4 | -2.499e+0 |
| tshz3 | teashirt zinc finger family member 3 | 8.495e-5 | -2.504e+0 |
| c430042m11rik | RIKEN cDNA C430042M11 gene | 2.131e-6 | -2.506e+0 |
| ppbp | pro-platelet basic protein | 3.608e-2 | -2.508e+0 |
| csf1r | colony stimulating factor 1 receptor | 8.056e-5 | -2.509e+0 |
| padi2 | peptidyl arginine deiminase, type II | 6.507e-6 | -2.509e+0 |
| myadm | myeloid-associated differentiation marker | 1.635e-7 | -2.513e+0 |
| aw112010 | expressed sequence AW112010 | 1.005e-2 | -2.517e+0 |
| stx11 | syntaxin 11 | 5.030e-5 | -2.521e+0 |
| relb | avian reticuloendotheliosis viral (v-rel) oncogene related B | 2.024e-6 | -2.523e+0 |
| mpo | myeloperoxidase | 4.891e-7 | -2.524e+0 |
| clec7a | C-type lectin domain family 7, member a | 2.640e-2 | -2.524e+0 |
| ab124611 | cDNA sequence AB124611 | 3.364e-3 | -2.526e+0 |
| rgs16 | regulator of G-protein signaling 16 | 2.921e-6 | -2.535e+0 |
| agpat9 | 1-acylglycerol-3-phosphate O-acyltransferase 9 | 4.613e-3 | -2.535e+0 |
| gpr160 | G protein-coupled receptor 160 | 7.688e-5 | -2.536e+0 |
| emp1 | epithelial membrane protein 1 | 1.145e-5 | -2.536e+0 |
| slc35d3 | solute carrier family 35, member D3 | 8.403e-6 | -2.537e+0 |
| itih5 | inter-alpha (globulin) inhibitor H5 | 1.785e-5 | -2.537e+0 |
| ccr1 | chemokine (C-C motif) receptor 1 | 1.442e-2 | -2.538e+0 |
| plau | plasminogen activator, urokinase | 1.289e-2 | -2.540e+0 |
| gpr183 | G protein-coupled receptor 183 | 2.370e-5 | -2.546e+0 |
| ly6e | lymphocyte antigen 6 complex, locus E | 3.104e-6 | -2.551e+0 |
| bcl2l11 | BCL2-like 11 (apoptosis facilitator) | 9.921e-7 | -2.553e+0 |
| oosp1 | oocyte secreted protein 1 | 1.531e-4 | -2.553e+0 |
| gzmc | granzyme C | 9.722e-4 | -2.564e+0 |
| ramp3 | receptor (calcitonin) activity modifying protein 3 | 1.374e-5 | -2.568e+0 |
| slfn10 | schlafen 10 | 5.594e-4 | -2.574e+0 |
| bc013712 | cDNA sequence BC013712 | 1.973e-4 | -2.579e+0 |
| tgtp | T-cell specific GTPase | 1.953e-3 | -2.589e+0 |
| akna | AT-hook transcription factor | 7.585e-8 | -2.598e+0 |
| gpr132 | G protein-coupled receptor 132 | 1.820e-6 | -2.598e+0 |
| flrt3 | fibronectin leucine rich transmembrane protein 3 | 7.830e-4 | -2.602e+0 |
| cd274 | CD274 antigen | 1.655e-3 | -2.602e+0 |
| kcnn4 | potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 | 5.085e-6 | -2.606e+0 |
| rrad | Ras-related associated with diabetes | 1.233e-6 | -2.612e+0 |
| atp10a | ATPase, class V, type 10A | 1.041e-6 | -2.614e+0 |
| mylk3 | myosin light chain kinase 3 | 2.834e-4 | -2.616e+0 |
| krt8 | keratin 8 | 1.208e-2 | -2.618e+0 |
| il1rl1 | interleukin 1 receptor-like 1 | 2.496e-5 | -2.618e+0 |
| h2-dmb1 | histocompatibility 2, class II, locus Mb1 | 5.567e-3 | -2.622e+0 |
| klf6 | Kruppel-like factor 6 | 7.361e-6 | -2.630e+0 |
| 1200002n14rik | RIKEN cDNA 1200002N14 gene | 1.905e-3 | -2.630e+0 |
| 3110001a13rik | RIKEN cDNA 3110001A13 gene | 7.800e-6 | -2.646e+0 |
| h19 | H19 fetal liver mRNA | 1.148e-3 | -2.647e+0 |
| h2-gs10 | MHC class I like protein GS10 | 5.423e-3 | -2.651e+0 |
| slfn3 | schlafen 3 | 5.219e-4 | -2.652e+0 |
| scin | scinderin | 4.651e-8 | -2.654e+0 |
| ttpa | tocopherol (alpha) transfer protein | 4.653e-6 | -2.667e+0 |
| ccl5 | chemokine (C-C motif) ligand 5 | 1.374e-2 | -2.670e+0 |
| nedd9 | neural precursor cell expressed, developmentally down-regulated gene 9 | 3.032e-8 | -2.677e+0 |
| fcgr4 | Fc receptor, IgG, low affinity IV | 1.285e-2 | -2.688e+0 |
| car9 | carbonic anhydrase 9 | 7.121e-5 | -2.689e+0 |
| ezr | ezrin | 1.293e-7 | -2.692e+0 |
| nfkbid | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, delta | 3.364e-5 | -2.696e+0 |
| nlrp3 | NLR family, pyrin domain containing 3 | 1.015e-3 | -2.704e+0 |
| axud1 | AXIN1 up-regulated 1 | 3.013e-5 | -2.709e+0 |
| ptpn22 | protein tyrosine phosphatase, non-receptor type 22 (lymphoid) | 5.013e-5 | -2.714e+0 |
| krt18 | keratin 18 | 1.304e-3 | -2.719e+0 |
| rpl39l | ribosomal protein L39-like | 5.726e-5 | -2.720e+0 |
| 1200016e24rik | RIKEN cDNA 1200016E24 gene | 2.183e-5 | -2.720e+0 |
| clec4n | C-type lectin domain family 4, member n | 3.454e-2 | -2.730e+0 |
| pla2g7 | phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) | 1.301e-2 | -2.735e+0 |
| hlf | hepatic leukemia factor | 7.797e-6 | -2.736e+0 |
| c1qa | complement component 1, q subcomponent, alpha polypeptide | 1.756e-2 | -2.738e+0 |
| marveld2 | MARVEL (membrane-associating) domain containing 2 | 7.871e-6 | -2.747e+0 |
| rassf5 | Ras association (RalGDS/AF-6) domain family member 5 | 2.358e-7 | -2.750e+0 |
| smpdl3a | sphingomyelin phosphodiesterase, acid-like 3A | 9.166e-5 | -2.751e+0 |
| fcgr1 | Fc receptor, IgG, high affinity I | 7.958e-3 | -2.754e+0 |
| cd33 | CD33 antigen | 8.217e-5 | -2.756e+0 |
| cpt1a | carnitine palmitoyltransferase 1a, liver | 3.743e-6 | -2.760e+0 |
| hist1h2bc | histone cluster 1, H2bc | 2.248e-7 | -2.767e+0 |
| sell | selectin, lymphocyte | 4.495e-5 | -2.777e+0 |
| clec4d | C-type lectin domain family 4, member d | 3.216e-4 | -2.787e+0 |
| tgif1 | TGFB-induced factor homeobox 1 | 5.052e-4 | -2.789e+0 |
| fcgr2b | Fc receptor, IgG, low affinity IIb | 6.883e-4 | -2.792e+0 |
| lgmn | legumain | 8.165e-3 | -2.803e+0 |
| trem1 | triggering receptor expressed on myeloid cells 1 | 3.368e-4 | -2.810e+0 |
| 5830416p10rik | RIKEN cDNA 5830416P10 gene | 6.054e-7 | -2.812e+0 |
| s100a6 | S100 calcium binding protein A6 (calcyclin) | 3.140e-3 | -2.816e+0 |
| cd53 | CD53 antigen | 2.056e-4 | -2.816e+0 |
| gadd45b | growth arrest and DNA-damage-inducible 45 beta | 1.396e-5 | -2.824e+0 |
| klrd1 | killer cell lectin-like receptor, subfamily D, member 1 | 1.564e-6 | -2.826e+0 |
| eltd1 | EGF, latrophilin seven transmembrane domain containing 1 | 4.860e-6 | -2.826e+0 |
| atp8b4 | ATPase, class I, type 8B, member 4 | 8.238e-5 | -2.827e+0 |
| bcl2a1a | B-cell leukemia/lymphoma 2 related protein A1a | 5.065e-3 | -2.828e+0 |
| anxa1 | annexin A1 | 4.694e-5 | -2.842e+0 |
| btk | Bruton agammaglobulinemia tyrosine kinase | 2.125e-5 | -2.842e+0 |
| ptgs2 | prostaglandin-endoperoxide synthase 2 | 6.991e-3 | -2.858e+0 |
| tnfsf9 | tumor necrosis factor (ligand) superfamily, member 9 | 1.344e-2 | -2.870e+0 |
| itgax | integrin alpha X | 2.497e-3 | -2.871e+0 |
| rab20 | RAB20, member RAS oncogene family | 8.132e-3 | -2.877e+0 |
| emr1 | EGF-like module containing, mucin-like, hormone receptor-like sequence 1 | 5.762e-3 | -2.888e+0 |
| lonrf3 | LON peptidase N-terminal domain and ring finger 3 | 2.727e-6 | -2.900e+0 |
| ear3 | eosinophil-associated, ribonuclease A family, member 3 | 1.254e-2 | -2.902e+0 |
| ebi3 | Epstein-Barr virus induced gene 3 | 1.136e-6 | -2.903e+0 |
| fpr2 | formyl peptide receptor 2 | 7.467e-3 | -2.909e+0 |
| 6330500d04rik | RIKEN cDNA 6330500D04 gene | 9.428e-7 | -2.916e+0 |
| bc006779 | cDNA sequence BC006779 | 2.200e-5 | -2.927e+0 |
| h2-t23 | histocompatibility 2, T region locus 23 | 3.454e-5 | -2.936e+0 |
| maff | v-maf musculoaponeurotic fibrosarcoma oncogene family, protein F (avian) | 2.114e-5 | -2.939e+0 |
| c1qc | complement component 1, q subcomponent, C chain | 1.723e-2 | -2.944e+0 |
| 1100001h23rik | RIKEN cDNA 1100001H23 gene | 1.425e-3 | -2.946e+0 |
| cd68 | CD68 antigen | 8.231e-3 | -2.954e+0 |
| sgk1 | serum/glucocorticoid regulated kinase 1 | 5.234e-4 | -2.957e+0 |
| lyz2 | lysozyme 2 | 5.842e-4 | -2.962e+0 |
| slco3a1 | solute carrier organic anion transporter family, member 3a1 | 2.486e-7 | -2.970e+0 |
| trfr2 | transferrin receptor 2 | 1.575e-6 | -2.971e+0 |
| h2-l | histocompatibility 2, D region | 1.234e-5 | -2.983e+0 |
| gbp3 | guanylate binding protein 3 | 6.693e-5 | -2.984e+0 |
| 3830612m24 | hypothetical protein 3830612M24 | 6.153e-6 | -2.996e+0 |
| cdh17 | cadherin 17 | 2.613e-5 | -3.005e+0 |
| cdk6 | cyclin-dependent kinase 6 | 3.350e-8 | -3.013e+0 |
| pkib | protein kinase inhibitor beta, cAMP dependent, testis specific | 4.771e-5 | -3.019e+0 |
| arg2 | arginase type II | 1.167e-2 | -3.027e+0 |
| zfp36 | zinc finger protein 36 | 8.994e-6 | -3.032e+0 |
| plaur | plasminogen activator, urokinase receptor | 6.540e-6 | -3.033e+0 |
| 5930433n17rik | RIKEN cDNA 5930433N17 gene | 8.669e-6 | -3.042e+0 |
| arhgap15 | Rho GTPase activating protein 15 | 1.073e-7 | -3.043e+0 |
| s100a11 | S100 calcium binding protein A11 (calgizzarin) | 2.139e-10 | -3.048e+0 |
| srgn | serglycin | 7.314e-6 | -3.051e+0 |
| mmp13 | matrix metallopeptidase 13 | 3.104e-2 | -3.056e+0 |
| hck | hemopoietic cell kinase | 3.516e-3 | -3.061e+0 |
| cd36 | CD36 antigen | 5.211e-3 | -3.061e+0 |
| ifitm1 | interferon induced transmembrane protein 1 | 4.678e-7 | -3.064e+0 |
| cyfip2 | cytoplasmic FMR1 interacting protein 2 | 9.406e-9 | -3.066e+0 |
| antxr2 | anthrax toxin receptor 2 | 7.696e-6 | -3.071e+0 |
| trf | transferrin | 1.077e-5 | -3.073e+0 |
| map3k8 | mitogen-activated protein kinase kinase kinase 8 | 8.440e-5 | -3.074e+0 |
| stfa1 | stefin A1 | 4.097e-3 | -3.087e+0 |
| pira6 | paired-Ig-like receptor A6 | 5.697e-5 | -3.090e+0 |
| lsp1 | lymphocyte specific 1 | 1.021e-6 | -3.090e+0 |
| havcr2 | hepatitis A virus cellular receptor 2 | 9.893e-4 | -3.092e+0 |
| ugt1a6a | UDP glucuronosyltransferase 1 family, polypeptide A6A | 3.887e-5 | -3.095e+0 |
| il7r | interleukin 7 receptor | 2.318e-3 | -3.136e+0 |
| slfn2 | schlafen 2 | 4.315e-3 | -3.145e+0 |
| 2210010l05rik | RIKEN cDNA 2210010L05 gene | 4.035e-8 | -3.151e+0 |
| h2-m3 | histocompatibility 2, M region locus 3 | 6.017e-4 | -3.167e+0 |
| xlr3a | X-linked lymphocyte-regulated 3A | 7.922e-6 | -3.171e+0 |
| parvg | parvin, gamma | 1.040e-5 | -3.182e+0 |
| ctsg | cathepsin G | 2.134e-5 | -3.192e+0 |
| gpr171 | G protein-coupled receptor 171 | 1.646e-5 | -3.197e+0 |
| ai426953 | expressed sequence AI426953 | 2.859e-5 | -3.197e+0 |
| plac8 | placenta-specific 8 | 2.727e-6 | -3.206e+0 |
| s100a4 | S100 calcium binding protein A4 | 3.448e-3 | -3.210e+0 |
| rsad2 | radical S-adenosyl methionine domain containing 2 | 2.759e-3 | -3.225e+0 |
| ifi203 | interferon activated gene 203 | 1.828e-5 | -3.233e+0 |
| ccrl2 | chemokine (C-C motif) receptor-like 2 | 1.594e-3 | -3.236e+0 |
| basp1 | brain abundant, membrane attached signal protein 1 | 6.890e-7 | -3.240e+0 |
| pld4 | phospholipase D family, member 4 | 3.857e-5 | -3.244e+0 |
| coro2a | coronin, actin binding protein 2A | 9.455e-8 | -3.250e+0 |
| egr1 | early growth response 1 | 1.873e-6 | -3.251e+0 |
| ankrd57 | ankyrin repeat domain 57 | 9.040e-4 | -3.255e+0 |
| ccr7 | chemokine (C-C motif) receptor 7 | 4.361e-5 | -3.255e+0 |
| pmaip1 | phorbol-12-myristate-13-acetate-induced protein 1 | 1.033e-6 | -3.258e+0 |
| tnfrsf13c | tumor necrosis factor receptor superfamily, member 13c | 1.705e-6 | -3.266e+0 |
| bcl3 | B-cell leukemia/lymphoma 3 | 2.593e-8 | -3.274e+0 |
| rel | reticuloendotheliosis oncogene | 2.516e-5 | -3.275e+0 |
| tnfaip3 | tumor necrosis factor, alpha-induced protein 3 | 6.537e-5 | -3.275e+0 |
| apob48r | apolipoprotein B48 receptor | 1.766e-7 | -3.275e+0 |
| pygl | liver glycogen phosphorylase | 1.743e-6 | -3.276e+0 |
| myo1g | myosin IG | 1.700e-7 | -3.278e+0 |
| nfkbie | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | 5.139e-6 | -3.282e+0 |
| wdfy4 | WD repeat and FYVE domain containing 4 | 6.180e-9 | -3.294e+0 |
| phf11 | PHD finger protein 11 | 4.801e-3 | -3.298e+0 |
| ptprc | protein tyrosine phosphatase, receptor type, C | 2.007e-5 | -3.302e+0 |
| gimap6 | GTPase, IMAP family member 6 | 1.022e-6 | -3.305e+0 |
| hoxa9 | homeo box A9 | 7.429e-7 | -3.322e+0 |
| adrb2 | adrenergic receptor, beta 2 | 3.558e-5 | -3.324e+0 |
| gm885 | gene model 885, (NCBI) | 1.568e-5 | -3.330e+0 |
| nuak2 | NUAK family, SNF1-like kinase, 2 | 1.802e-6 | -3.331e+0 |
| ccl12 | chemokine (C-C motif) ligand 12 | 3.254e-2 | -3.360e+0 |
| slc28a2 | solute carrier family 28 (sodium-coupled nucleoside transporter), member 2 | 4.258e-5 | -3.361e+0 |
| itgal | integrin alpha L | 2.605e-10 | -3.364e+0 |
| 4631422o05rik | RIKEN cDNA 4631422O05 gene | 1.951e-6 | -3.368e+0 |
| ddx3y | DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, Y-linked | 2.867e-7 | -3.374e+0 |
| btla | B and T lymphocyte associated | 7.469e-6 | -3.379e+0 |
| il6 | interleukin 6 | 5.794e-3 | -3.406e+0 |
| 5330406m23rik | RIKEN cDNA 5330406M23 gene | 2.658e-6 | -3.410e+0 |
| ddx4 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 4 | 9.914e-6 | -3.455e+0 |
| slc15a3 | solute carrier family 15, member 3 | 1.083e-3 | -3.457e+0 |
| 5133401h06rik | RIKEN cDNA 5133401H06 gene | 3.326e-4 | -3.460e+0 |
| 2610034m16rik | RIKEN cDNA 2610034M16 gene | 5.195e-6 | -3.465e+0 |
| pira1 | paired-Ig-like receptor A1 | 6.445e-7 | -3.477e+0 |
| ifi204 | interferon activated gene 204 | 1.395e-2 | -3.481e+0 |
| areg | amphiregulin | 2.170e-3 | -3.483e+0 |
| 2210403k04rik | RIKEN cDNA 2210403K04 gene | 4.923e-7 | -3.487e+0 |
| slc11a1 | solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1 | 3.133e-3 | -3.500e+0 |
| adam8 | a disintegrin and metallopeptidase domain 8 | 6.509e-4 | -3.502e+0 |
| ada | adenosine deaminase | 1.688e-5 | -3.508e+0 |
| spn | sialophorin | 1.561e-7 | -3.509e+0 |
| 4930519l02rik | RIKEN cDNA 4930519L02 gene | 7.104e-5 | -3.516e+0 |
| nfkbia | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 4.633e-8 | -3.523e+0 |
| emilin2 | elastin microfibril interfacer 2 | 2.143e-7 | -3.537e+0 |
| prdm1 | PR domain containing 1, with ZNF domain | 2.705e-6 | -3.541e+0 |
| loc73899 | hypothetical LOC73899 | 4.592e-6 | -3.548e+0 |
| atf3 | activating transcription factor 3 | 4.130e-5 | -3.577e+0 |
| egr2 | early growth response 2 | 1.300e-3 | -3.583e+0 |
| icam1 | intercellular adhesion molecule 1 | 7.237e-10 | -3.601e+0 |
| ccl4 | chemokine (C-C motif) ligand 4 | 4.517e-4 | -3.611e+0 |
| c330011k17rik | RIKEN cDNA C330011K17 gene | 9.431e-8 | -3.614e+0 |
| il1a | interleukin 1 alpha | 2.548e-3 | -3.628e+0 |
| ier3 | immediate early response 3 | 1.075e-8 | -3.648e+0 |
| ms4a6c | membrane-spanning 4-domains, subfamily A, member 6C | 1.898e-3 | -3.652e+0 |
| 100042856 | predicted gene, 100042856 | 1.170e-5 | -3.653e+0 |
| parp8 | poly (ADP-ribose) polymerase family, member 8 | 4.228e-7 | -3.660e+0 |
| ocln | occludin | 1.131e-6 | -3.661e+0 |
| rnase4 | ribonuclease, RNase A family 4 | 1.870e-5 | -3.700e+0 |
| il10 | interleukin 10 | 4.771e-3 | -3.718e+0 |
| 9830134c10rik | RIKEN cDNA 9830134C10 gene | 1.786e-6 | -3.724e+0 |
| ai504432 | expressed sequence AI504432 | 2.558e-7 | -3.725e+0 |
| slc22a3 | solute carrier family 22 (organic cation transporter), member 3 | 3.964e-6 | -3.732e+0 |
| ly6a | lymphocyte antigen 6 complex, locus A | 7.049e-5 | -3.743e+0 |
| gm2a | GM2 ganglioside activator protein | 1.688e-6 | -3.761e+0 |
| bank1 | B-cell scaffold protein with ankyrin repeats 1 | 1.261e-6 | -3.776e+0 |
| osm | oncostatin M | 7.646e-4 | -3.778e+0 |
| speer1-ps1 | spermatogenesis associated glutamate (E)-rich protein 1, pseudogene 1 | 1.565e-5 | -3.785e+0 |
| gzmd | granzyme D | 1.917e-3 | -3.789e+0 |
| serpina3g | serine (or cysteine) peptidase inhibitor, clade A, member 3G | 4.316e-7 | -3.804e+0 |
| ly9 | lymphocyte antigen 9 | 1.978e-5 | -3.804e+0 |
| pdpn | podoplanin | 3.701e-3 | -3.805e+0 |
| mbnl3 | muscleblind-like 3 (Drosophila) | 4.738e-7 | -3.821e+0 |
| clec4a3 | C-type lectin domain family 4, member a3 | 1.070e-2 | -3.824e+0 |
| ifi27 | interferon, alpha-inducible protein 27 | 2.929e-3 | -3.832e+0 |
| lpxn | leupaxin | 1.503e-4 | -3.847e+0 |
| nfil3 | nuclear factor, interleukin 3, regulated | 1.869e-6 | -3.881e+0 |
| ccl7 | chemokine (C-C motif) ligand 7 | 8.491e-3 | -3.892e+0 |
| flt3 | FMS-like tyrosine kinase 3 | 8.523e-7 | -3.895e+0 |
| tnf | tumor necrosis factor | 3.042e-4 | -3.930e+0 |
| niban | niban protein | 4.647e-8 | -3.950e+0 |
| nkg7 | natural killer cell group 7 sequence | 8.644e-7 | -3.955e+0 |
| cd14 | CD14 antigen | 2.837e-3 | -3.960e+0 |
| eg622976 | predicted gene, EG622976 | 5.876e-3 | -3.974e+0 |
| sfxn3 | sideroflexin 3 | 1.166e-6 | -3.990e+0 |
| c030046g05 | hypothetical protein C030046G05 | 1.241e-9 | -4.004e+0 |
| loc100044979 | similar to Gpr137b protein | 2.145e-6 | -4.010e+0 |
| fyb | FYN binding protein | 1.661e-5 | -4.018e+0 |
| cd27 | CD27 antigen | 6.188e-6 | -4.041e+0 |
| ly6c1 | lymphocyte antigen 6 complex, locus C1 | 2.079e-3 | -4.045e+0 |
| p2ry10 | purinergic receptor P2Y, G-protein coupled 10 | 2.096e-6 | -4.055e+0 |
| dusp1 | dual specificity phosphatase 1 | 1.572e-6 | -4.062e+0 |
| 0610037m15rik | RIKEN cDNA 0610037M15 gene | 3.309e-4 | -4.074e+0 |
| ptger4 | prostaglandin E receptor 4 (subtype EP4) | 3.389e-5 | -4.081e+0 |
| serpinb1a | serine (or cysteine) peptidase inhibitor, clade B, member 1a | 4.492e-6 | -4.084e+0 |
| lcp1 | lymphocyte cytosolic protein 1 | 4.387e-8 | -4.087e+0 |
| cybb | cytochrome b-245, beta polypeptide | 2.115e-4 | -4.118e+0 |
| h2-aa | histocompatibility 2, class II antigen A, alpha | 9.700e-5 | -4.126e+0 |
| ccl2 | chemokine (C-C motif) ligand 2 | 3.061e-3 | -4.153e+0 |
| oasl2 | 2'-5' oligoadenylate synthetase-like 2 | 1.544e-4 | -4.159e+0 |
| h2-eb1 | histocompatibility 2, class II antigen E beta | 2.900e-4 | -4.165e+0 |
| ear2 | eosinophil-associated, ribonuclease A family, member 2 | 2.617e-3 | -4.179e+0 |
| ctsh | cathepsin H | 1.113e-3 | -4.183e+0 |
| cd74 | CD74 antigen (invariant polypeptide of major histocompatibility complex, class II antigen-associated) | 4.056e-4 | -4.205e+0 |
| ms4a6b | membrane-spanning 4-domains, subfamily A, member 6B | 1.965e-3 | -4.228e+0 |
| xist | inactive X specific transcripts | 6.466e-7 | -4.238e+0 |
| pyhin1 | pyrin and HIN domain family, member 1 | 5.558e-4 | -4.248e+0 |
| casp4 | caspase 4, apoptosis-related cysteine peptidase | 6.343e-6 | -4.249e+0 |
| lilrb4 | leukocyte immunoglobulin-like receptor, subfamily B, member 4 | 2.165e-6 | -4.253e+0 |
| cxcl1 | chemokine (C-X-C motif) ligand 1 | 1.197e-3 | -4.281e+0 |
| ifi47 | interferon gamma inducible protein 47 | 4.099e-6 | -4.282e+0 |
| a130040m12rik | RIKEN cDNA A130040M12 gene | 3.163e-8 | -4.293e+0 |
| rmcs5 | response to metastatic cancers 5 | 7.754e-5 | -4.397e+0 |
| hdc | histidine decarboxylase | 2.546e-8 | -4.414e+0 |
| gpr65 | G-protein coupled receptor 65 | 2.132e-5 | -4.418e+0 |
| c1qb | complement component 1, q subcomponent, beta polypeptide | 4.063e-3 | -4.436e+0 |
| gzmb | granzyme B | 1.081e-7 | -4.462e+0 |
| aif1 | allograft inflammatory factor 1 | 2.587e-3 | -4.510e+0 |
| ai607873 | expressed sequence AI607873 | 1.356e-3 | -4.511e+0 |
| socs3 | suppressor of cytokine signaling 3 | 3.562e-5 | -4.526e+0 |
| selplg | selectin, platelet (p-selectin) ligand | 2.953e-10 | -4.563e+0 |
| ly86 | lymphocyte antigen 86 | 2.136e-4 | -4.592e+0 |
| 1190002h23rik | RIKEN cDNA 1190002H23 gene | 2.776e-7 | -4.613e+0 |
| traf1 | Tnf receptor-associated factor 1 | 3.008e-8 | -4.627e+0 |
| klf4 | Kruppel-like factor 4 (gut) | 2.797e-6 | -4.636e+0 |
| ms4a4c | membrane-spanning 4-domains, subfamily A, member 4C | 1.574e-3 | -4.656e+0 |
| dock10 | dedicator of cytokinesis 10 | 1.725e-7 | -4.661e+0 |
| glipr1 | GLI pathogenesis-related 1 (glioma) | 1.564e-7 | -4.695e+0 |
| s100a8 | S100 calcium binding protein A8 (calgranulin A) | 6.376e-4 | -4.701e+0 |
| dusp5 | dual specificity phosphatase 5 | 7.503e-11 | -4.710e+0 |
| lincr | lung-inducible neuralized-related C3HC4 RING domain protein | 4.197e-7 | -4.712e+0 |
| h2-q7 | histocompatibility 2, Q region locus 7 | 6.101e-5 | -4.721e+0 |
| nfkbiz | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta | 1.179e-8 | -4.726e+0 |
| cytip | cytohesin 1 interacting protein | 3.208e-7 | -4.761e+0 |
| tgfbi | transforming growth factor, beta induced | 1.192e-4 | -4.781e+0 |
| il1r2 | interleukin 1 receptor, type II | 1.243e-8 | -4.791e+0 |
| ottmusg00000000971 | predicted gene, OTTMUSG00000000971 | 4.399e-5 | -4.803e+0 |
| lgals3 | lectin, galactose binding, soluble 3 | 6.357e-5 | -4.835e+0 |
| stap1 | signal transducing adaptor family member 1 | 2.008e-6 | -4.856e+0 |
| spp1 | secreted phosphoprotein 1 | 7.525e-4 | -4.858e+0 |
| olr1 | oxidized low density lipoprotein (lectin-like) receptor 1 | 1.140e-5 | -4.879e+0 |
| loc215866 | hypothetical protein LOC215866 | 9.669e-7 | -4.896e+0 |
| mpeg1 | macrophage expressed gene 1 | 1.919e-4 | -4.909e+0 |
| hspa1b | heat shock protein 1B | 1.534e-9 | -5.021e+0 |
| 1810015c04rik | RIKEN cDNA 1810015C04 gene | 2.040e-9 | -5.118e+0 |
| aa467197 | expressed sequence AA467197 | 1.774e-5 | -5.158e+0 |
| clec4e | C-type lectin domain family 4, member e | 3.029e-6 | -5.322e+0 |
| fosb | FBJ osteosarcoma oncogene B | 2.192e-7 | -5.325e+0 |
| il1b | interleukin 1 beta | 1.550e-4 | -5.326e+0 |
| slfn4 | schlafen 4 | 2.392e-4 | -5.421e+0 |
| bhlhb2 | basic helix-loop-helix domain containing, class B2 | 3.513e-8 | -5.434e+0 |
| chi3l3 | chitinase 3-like 3 | 4.233e-4 | -5.454e+0 |
| cxcl10 | chemokine (C-X-C motif) ligand 10 | 5.623e-7 | -5.486e+0 |
| nr4a1 | nuclear receptor subfamily 4, group A, member 1 | 2.737e-9 | -5.513e+0 |
| irg1 | immunoresponsive gene 1 | 7.244e-6 | -5.514e+0 |
| cpa3 | carboxypeptidase A3, mast cell | 3.602e-8 | -5.657e+0 |
| rgs1 | regulator of G-protein signaling 1 | 5.312e-7 | -5.709e+0 |
| s100a9 | S100 calcium binding protein A9 (calgranulin B) | 1.181e-4 | -5.752e+0 |
| cd69 | CD69 antigen | 1.602e-6 | -5.754e+0 |
| cxcl3 | chemokine (C-X-C motif) ligand 3 | 1.089e-4 | -5.861e+0 |
| hspa1a | heat shock protein 1A | 2.545e-8 | -5.890e+0 |
| ai662270 | expressed sequence AI662270 | 8.825e-10 | -6.202e+0 |
| xlr4b | X-linked lymphocyte-regulated 4B | 3.410e-9 | -6.216e+0 |
| cxcr4 | chemokine (C-X-C motif) receptor 4 | 6.933e-7 | -6.284e+0 |
| fos | FBJ osteosarcoma oncogene | 1.888e-6 | -6.319e+0 |
| ifi205 | interferon activated gene 205 | 4.342e-7 | -6.464e+0 |
| cd48 | CD48 antigen | 1.514e-8 | -6.505e+0 |
| cd83 | CD83 antigen | 8.554e-8 | -6.590e+0 |
| ctss | cathepsin S | 4.932e-7 | -7.819e+0 |
| cxcl2 | chemokine (C-X-C motif) ligand 2 | 5.893e-8 | -8.295e+0 |